The Global IVD Antibodies Industry is poised for robust growth, with a projected Compound Annual Growth Rate (CAGR) of approximately 3.8% during the forecast period spanning from 2022 to 2032. This ascension is expected to culminate in a valuation of nearly US$ 2 Billion by the year 2032. The driving force behind this anticipated surge …